Articles tagged with Viral Infections
Studies found that even mildly premature infants have a higher risk of medically attended RSV infection, especially those exposed to supplemental oxygen. Researchers detected an increased risk even in babies born at 37 weeks.
A recent study found that even mild prematurity increases risk of medically attended RSV infection, with highest risks among babies born between 33-36 weeks gestational age. This research contributes to growing evidence that late-preterm infants face greater morbidity and healthcare costs.
A human monoclonal antibody developed by Massachusetts Biologic Laboratories (MBL) neutralizes the Hepatitis C virus and prevents infection in a pre-clinical animal model. The antibody could be used as a therapy shortly before and after transplant surgery to prevent re-infection.
Researchers found that patients with chronic hepatitis C who have achieved a sustained viral response often still carry miniscule amounts of the virus in their bodies. These trace remainders are thought to be infectious, posing a risk to others.
A parasitic bacterium may reduce mosquito lifespan and limit dengue fever transmission. Infected mosquitoes become more active as they age, but their activity levels don't increase further.
Researchers found that combining workplace non-attendance, school closure, isolating infected family members, and reducing community contact can significantly reduce the rate of development and overall burden of influenza epidemics. Interventions must be introduced within 2 weeks of the first case to prevent an epidemic developing.
A Kansas State University researcher has found that the 1918 Spanish flu pandemic virus and the current swine influenza virus are closely related, with the former adapting to pigs and resulting in the latter. The study suggests that pigs may have played a role in maintaining and spreading the virus.
Researchers found that after reassortment with a human influenza virus, an avian flu virus requires relatively few mutations to spread rapidly between mammals by respiratory droplets. This process is similar to the formation of the current swine flu outbreak, suggesting a potential link between avian and human influenza viruses.
A novel H1N1 swine influenza A virus has spread rapidly around the world, infecting over 60 people and causing seven deaths. The WHO has activated its emergency response room to coordinate global efforts to contain the outbreak.
A DNA-based therapeutic vaccination has shown antiviral effects in patients with chronic hepatitis C, with 67% experiencing significant reductions in viral load. The vaccine, developed using naked DNA delivered by electroporation, was found to induce immune responses and activate the host T cell response in patients.
Researchers have identified 116 host factors essential for successful dengue infection in fruit flies, with at least one also necessary for mosquito infection. The study opens doors to new ways to prevent or treat the disease, which infects millions globally each year.
Researchers have identified cellular components in mosquitoes and humans that the dengue virus uses to multiply, paving the way for potential treatments. The study found 116 host factors, including 42 with human counterparts, which may serve as targets for new drugs.
Researchers discovered Nosema ceranae, a Microsporidia parasite, is the primary cause of honey bee colony depopulation syndrome in professional apiaries. Treating infected colonies with flumagillin resulted in complete recovery.
A groundbreaking CSIRO study has defined the period when horses are most likely to shed Hendra virus, enabling early diagnosis and prevention of transmission. This breakthrough aims to reduce the risk of spread to both humans and susceptible horses.
The recent special edition of Virology journal explores the past, present, and future of small DNA tumor viruses, including polyomaviruses, adenoviruses, and papillomaviruses. These viruses have led to fundamental discoveries in basic biology, unraveling complex aspects of host cells.
A study found that periodontal disease caused by Porphyromonas gingivalis can reactivate latent HIV-1 in infected individuals. The bacteria induce histone acetylation, leading to HIV-1 reactivation. Maintaining oral hygiene is crucial for preventing AIDS progression.
Researchers at MDC Berlin-Buch discovered a mechanism to prevent viral myocarditis by blocking the Coxsackie-adenovirus-receptor. Genetically engineered mice without this receptor were protected from cardiac infection caused by the Coxsackievirus, showing that autoimmune response may not be the primary cause of disease process.
Researchers found that cannabinoids like THC have anticancer effects on human brain cancer cells by inducing autophagy. Additionally, lithium was shown to protect hippocampal nerve cells in mice treated with cranial radiation therapy, suggesting it may be a new approach to reducing long-term neurological side effects.
Astrocytes, star-shaped nerve cells, use specific machinery and recognition molecules to recognize viral invaders and initiate inflammation. This understanding may lead to new treatment strategies for viral infections of the brain and spinal cord.
A recent study published in PLOS Pathogens has revealed that a majority of the global population has been infected with three recently discovered human polyomaviruses, including KIV, WU, and MCV. The study, which tested over 2,200 anonymous donor blood samples, found that infection with these viruses occurs early in childhood.
Braunschweig Helmholtz researchers found that host genetic factors significantly impact the progression of influenza A virus infections. The study discovered strong differences in disease outcomes among mice with genetically identical immune systems, suggesting a genetic basis for varying responses to the flu virus.
A new study found that African Americans have lower rates of successful hepatitis C virus (HCV) therapy due to differences in antiviral activity induced by interferon. Early viral kinetic measurements within 24-48 hours of treatment can predict ultimate response rates.
A Phase II clinical trial found that the vaccine showed efficacy in mothers, with a significantly lower rate of CMV infection. The study used an experimental vaccine made from glycoprotein B and included an adjuvant to improve immune response.
A new experimental vaccine has shown promising results in preventing cytomegalovirus (CMV) infection in infants, reducing the risk by 50% compared to a saline injection. The vaccine was given to 441 CMV-negative women and found to be safe with minimal side effects.
A joint study from Helmholtz-Centre and immunologists found that flu infection facilitates and intensifies pneumonia bacteria infections. Researchers discovered that lack of immune cells does not cause increased susceptibility to superinfections.
Scientists have identified platelets as a contributor to organ failure in patients with sepsis. The study found that granzyme B production in platelets can cause cell death, leading to organ failure. Researchers hope this discovery will lead to better treatments and potentially even prevention of organ failure.
Researchers at Weill Cornell Medical College discovered that chloroquine is a highly active inhibitor of infection by Hendra and Nipah viruses. The drug blocks the action of cathepsin L, an enzyme essential for virus growth and maturation.
Researchers have developed new techniques to quickly identify bacterial infections and determine the best antibiotic treatment. A nanoparticle-based method can detect bacterial strains in hours, while scientists also uncovered genetic basis of morphological differences in anthrax letter material.
Researchers developed small molecules targeting Hsp90 in mitochondria to induce tumor cell death. This combinatorial approach may be more effective than targeting single signaling pathways. Gene therapy also restored muscle strength in a mouse model of muscular dystrophy by anchoring nNOS to the sarcolemma.
UAB researchers have developed a new method to produce and study HPV-18, which could lead to a better understanding of how the virus functions and causes diseases. The new approach allows for the reproduction of the entire infection cycle of HPV-18 in primary human skin cells, providing opportunities to understand its molecular mechani...
A briefcase-sized kit, called PADLOC, aims to detect plant diseases rapidly and accurately, allowing farmers to take action to prevent damage. The kit uses nanotechnology to measure microorganisms and provide real-time recommendations for farmers.
A study by researchers at the University of Illinois reveals that RIG-I, a cellular protein, can detect viral RNA and trigger an immune response in every cell type. The protein uses two major parts to distinguish between viral and self-RNA, using a unique 'triphosphate' tag.
Researchers at Rhode Island Hospital completed a study on flu transmission to better understand the impact of infection control measures during a possible flu pandemic. The study found that pre-symptomatic transmission of influenza may be more significant than previously thought, and that small-particle aerosols from infected individua...
Research found that IgA antibodies against HCV structural antigens are associated with necro-inflammatory activity, suggesting a potential marker for histological activity in chronic HCV infection. The study also revealed a broad and vigorous humoral response in chronic HCV infection, contrasting with weak cellular immune responses.
A NASA study successfully predicted the 2006-2007 Rift Valley fever outbreak in northeast Africa using a blend of climate measurements and satellite data. The prediction gave public health officials up to six weeks' notice, allowing them to implement disease mitigation measures and lessen human impact.
Scientists have turned a benign adeno-associated virus into a highly infectious form that can effectively deliver a gene to lung cells, potentially curing cystic fibrosis. The new strain was created by forcing evolution to increase infectivity several hundred-fold, overcoming previous limitations in gene therapy.
Researchers at the University of Texas Medical Branch discovered a major virulence factor for Rift Valley fever virus that has a dual mechanism. The protein NSs promotes viral replication by attacking a host cell protein, preventing interferon beta production and allowing the virus to replicate unchecked.
A study by Helmholtz Center researchers reveals that acute hepatitis B infection triggers chronic liver disease through altered T helper cell function. The team identified specific genes and immune mechanisms involved in the development of chronic hepatitis B, shedding light on potential diagnostic markers and treatment options.
A study analyzed histologic features of liver biopsies from 86 infants with intrahepatic neonatal cholestasis (IHNC) and found no significant differences among different etiologies. However, a significant difference was observed in IHNC of infectious etiology, presenting with more severe erythropoiesis.
Researchers discovered that mosquitoes use RNA interference to combat dengue virus, allowing the virus to multiply and be transmitted to humans. Genetic manipulation of this response could help stop dengue virus transmission by Aedes aegypti.
A breakthrough discovery by Washington University researchers has identified a technology that reduces infection by the Rice Tungro Disease virus, causing significant economic losses in agriculture. The technology involves transgenic rice plants that overexpress specific proteins, providing improved resistance to the virus.
A new report by the NIH finds that digestive diseases result in over 100 million outpatient visits and 13 million hospitalizations annually, with a total cost of $141.8 billion. The top 10 most costly digestive diseases include digestive cancers, liver disease, and gastroesophageal reflux disease.
A study by Ohio State University researchers suggests that the influenza virus can lead to excessive fluid buildup in the lungs, impairing oxygen supply. The research aims to develop a new therapy to address this issue, potentially reducing the need for ventilation.
A new study compared recent avian strain H5N1 with genetic ressortants of the 1918 virus, showing that H5N1 replicates rapidly and induces a lethal cytokine storm. The results highlight the threat of an avian flu pandemic and emphasize the need for improved emergency preparedness.
Researchers discovered that Oncostatin M improves interferon's antiviral effect, increasing immune response to viruses. This combination may be useful for treating chronic viral hepatitis and other tumors that don't respond to conventional therapy.
A study in mice identified Toll-like receptor 7 as a critical molecule in detecting West Nile virus and recruiting immune cells to clear the infection. The research suggests that drug therapies targeting this signaling pathway could enhance the immune response and promote clearance of the deadly virus.
Isolongifolenone, a natural compound found in the Tauroniro tree, has been proven effective in deterring mosquito bites and repelling ticks. The findings suggest that isolongifolenone could be a cost-effective alternative to DEET for protecting against blood-feeding arthropods.
A study published in New England Journal of Medicine found that most children with RSV infections between 1 and 5 years old were previously healthy and had no other risk factors. The study estimates that about 1 in 334 hospitalizations, 1 in 38 emergency department visits, and 1 in 13 primary care office visits occur due to RSV infection.
The University of Pittsburgh Graduate School of Public Health has been awarded a seven-year $11 million grant to coordinate the Hepatitis B Clinical Research Network, a consortium of 15 US and Canadian institutions. The network will conduct translational research on hepatitis B, aiming to find a lasting cure for the infection.
Researchers at Thomas Jefferson University discovered a key protein component involved in inflammation detection and reaction to cytoplasmic DNA produced by infections or tissue damage. AIM2, a tumor suppressor, induces cell death to prevent pathogen replication.
Research published in International Journal of Health Geographics links outbreaks of nephropathia epidemica, a rodent-borne disease, to global warming. Warmer weather and increased food sources for voles lead to population growth and disease transmission.
A team of Wisconsin researchers has discovered that birnessite, a common soil mineral, can penetrate and degrade the prion's armor. This finding may provide new methods for decontaminating soil and other environments where prions reside.
A large cohort study found that infection with hepatitis C virus significantly increases risk for pancreatic cancer, a previously under-examined association. The study, published in Hepatology, suggests that individuals infected with HCV should be closely monitored for this potentially fatal condition.
Researchers have solved the structure of VP35, a key part of the Ebola protein that interferes with host cell defense mechanisms. This discovery paves the way for designing drugs that can bind to and inhibit VP35 function, potentially neutralizing the Ebola virus.
The American College of Physicians emphasizes the need for enhanced infection control practices to prevent viral hepatitis outbreaks. Researchers also stress the importance of proper antibiotic treatment for health care-associated pneumonia, highlighting its more serious nature compared to community-acquired pneumonia.
Researchers found that grazing animals like deer and rabbits increase the prevalence of a viral plant disease by promoting the growth of aphid-preferred annual grasses. This study challenges previous theories suggesting that herbivores help contain or reduce disease, highlighting the complexity of natural ecosystems.
Researchers employed intravital two-photon microscopy to study immune cells in mice with viral meningitis. They found that T-cells didn't attack infected cells but instead recruited monocytes and neutrophils, which caused fatal seizures.
Scientists identify a common vulnerability in rotaviruses, enabling the development of a broad-spectrum treatment for severe diarrheal diseases. This breakthrough could lead to improved vaccines and medications to prevent or treat rotavirus infections.
A study from the Norwegian Institute of Public Health found no significant link between human parechovirus infections and typical symptoms in infants. However, researchers noticed an increase in parechovirus infection between 6-18 months, which could be due to factors such as maternal antibody loss or nursery exposure.
Researchers identified a small molecule called sfRNA that controls host response to viral infection. Targeting this molecule could lead to effective antiviral therapy for flavivirus diseases.